Jalota Deepika 4
4 · PMV Pharmaceuticals, Inc. · Filed Jan 22, 2024
Insider Transaction Report
Form 4
Jalota Deepika
Chief Development Officer
Transactions
- Award
Common Stock
2024-01-18+95,555→ 125,501 total - Award
Employee Stock Option (right to buy)
2024-01-18+225,095→ 225,095 totalExercise: $1.80Exp: 2034-01-18→ Common Stock (225,095 underlying)
Footnotes (2)
- [F1]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 30, 2025.
- [F2]Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024.